| 摘要 |
Novel 3-aminoindazoles of formula (I) are SGK-inhibitors and can be used for treating SGK-related diseases and illnesses such as diabetes, obesity, metabolic syndrome (dyslipidaemia), systemic and pulmonary hypertonia, cardiovascular diseases and renal diseases, and generally any type of fibroses and inflammatory processes. |
| 申请人 |
MERCK PATENT GMBH;DORSCH, DIETER;BURGDORF, LARS, THORE;GERICKE, ROLF;BEIER, NORBERT;MEDERSKI, WERNER;LANG, FLORIAN |
发明人 |
DORSCH, DIETER;BURGDORF, LARS, THORE;GERICKE, ROLF;BEIER, NORBERT;MEDERSKI, WERNER;LANG, FLORIAN |
